openPR Logo
Press release

Liver Disease Treatment Market Size by Key Manufacturers and Application 2019 with Share, Revenue and Forecast

01-04-2019 02:35 PM CET | Health & Medicine

Press release from: Allied Market Research

Liver Disease Treatment Market Size by Key Manufacturers

Liver Disease Treatment Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $19,536 million by 2022, registering a CAGR of 11.72% during the period 2016 - 2022. The antiviral drug segment held the major share of the total market in 2015 and is expected to maintain its lead throughout the forecast period. This is attributed to the high incidences of virus-infected liver diseases including Hepatitis. However, corticosteroid drug segment registered fastest growing segment during the forecast period.

Get the sample Report: https://www.alliedmarketresearch.com/request-sample/388?utm_source=openpr_Niranjan

The factors driving the liver disease treatment market are rapidly changing lifestyle patterns such as increasing consumption of alcohol, and unhealthy diets; and the increasing prevalence of liver diseases. In addition, growing geriatric population, increasing government and non-government awareness programs, and rising R&D investments for the development of novel therapies are also playing the pivotal role in the growth of the liver disease treatment market.

Moreover, owing to the patent expiry of several drugs such as Epivir- HBV, generic and biosimilar drugs market have more potential in the liver disease treatment arena. However, stringent government regulations for the approval of drugs, high cost incurred in R&D and risks of side-effects associated with liver disease medications is expected to hamper the growth of the market during the forecast period.

Purchase the Report: https://www.alliedmarketresearch.com/checkout/37423?utm_source=openpr_Niranjan

Key findings of Liver Disease Treatment Market:
• Corticosteroids drug is projected to be the fastest growing segment, registering a CAGR of 16.49% during the forecast period
• North America is expected to lead the market throughout 2022 and is projected to grow at a CAGR of 11.89%, during 2016 and 2022
• Asia-Pacific is expected to grow with a CAGR of around 12.51%, due to an increasing prevalence of liver diseases and increasing R&D investments in this region.

North America and Europe collectively accounted for more than two-fourth of the total liver disease treatment market in 2015, and are expected to maintain their position throughout the forecast period. This is due to the increasing prevalence of liver diseases, a growing geriatric population, and increased awareness about the various liver diseases and their treatment in these regions. In addition, advancement in R&D is anticipated in the development of novel drug therapy for the treatment of liver diseases.

The prompt players in the liver disease treatment market have adopted strategies such as innovative product launch, merger & acquisition, partnership and business expansion to gain maximum market share. The major companies profiled in the report include Gilead Science Inc., Bayer AG, AstraZeneca PLC, GlaxoSmithKline plc, Merck & Co. Inc, Sanofi AG, Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, and Johnson & Johnson Private Limited.

Report Content Overview:
1) MARKET OVERVIEW
1.1 Market definition and scope
1.2 Key Findings
1.2.1 Top impacting factor
1.2.2 Top winning strategies
1.3.3 Top investment pockets
1.3 Porters five forces analysis
1.3.1 Low bargaining power of suppliers due to a large number of suppliers and low switching cost
1.3.2 Moderate bargaining power of buyer due to a large number of the buyer, high product dependency and less switching cost.
1.3.3 Low threat of substitutes due to the low preference of substitutes and high brand loyalty
1.3.4 Low threat of new entrants due to the presence of dominant players and strict government regulations
1.3.5 Presence of numerous players, high existing barriers, high economic base increases the competition among rivalries
1.4 Market share analysis, 2015
1.5 Drivers
1.5.1 Rapidly changing lifestyle patterns such as increasing consumption of alcohol, and unhealthy diets
1.5.2 Increasing prevalence of liver diseases
1.5.3 Growing geriatric population
1.5.4 Increasing government and non-government awareness programs
1.5.5 Increasing R&D investments for the development of novel therapies
1.6 Restraint
1.6.1 Stringent government regulations
1.6.2 High cost incurred in drug R&D
1.6.3 Side effect associated with medication
1.7 Opportunities
1.7.1 Availability of generic and biosimilar drugs

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liver Disease Treatment Market Size by Key Manufacturers and Application 2019 with Share, Revenue and Forecast here

News-ID: 1472124 • Views: 178

More Releases from Allied Market Research

Overview Membrane Technology for Food and Beverage Processing Market Size, Share …
Membranes are natural or manufactured substances used for separation. They commonly serve the purpose of filter pads. Membranes, which are semi-permeable in nature (allow only selective compounds/substances to flow pass them) are easy to manufacture. These are gaining popularity in the process industry where purity of products is highly desired. Membranes are available in every shape and size and are required in numerous devices right from the water filter at
Cooking Appliances Market is Predicted to Grow High CAGR from 2019 to 2026
The cooking appliance include products such as microwaves, ovens, cook tops, and range hoods. Modern cooking appliance are used to provide ease to chefs. Also, with rapid depletion of natural resources such as LPG, and other petroleum products, there is an urgent need to use efficient and eco-friendly cooking appliances in kitchen. Key players are developing advance cooking appliances in order to increase their market share, and on the same
Power Bank Market Insights with Statistics and Growth Prediction 2018 to 2025
The growth of the global power bank market is driven by rising in demand for smartphones across the globe and an increase in sales of power banks on online portals & e-commerce websites. However, factors such as emerging trends of wireless charging and improved battery capacity of electronic devices hamper market growth. On the other hand, the development of solar & hydrogen fuel-based power banks and an increase in the
Shale Gas Market 2022 | Business Analysis and Evolutionary Growth
Shale gas is emerging as an ideal energy source, owing to its abundance, low carbon footprint and comparatively low price than conventional energy source such as natural gas, coal, nuclear and hydro. However, the issue of water scarcity due to the hydraulic fracturing technique may hamper its production. Moreover, the unstructured regulatory framework in the European countries may dampen its producers to some extent. The global shale gas consumption is

All 5 Releases


More Releases for R&D

High Performance Hovercraft Market - R&D Activities Opening New Opportunities
A hovercraft, also known as an air-cushion vehicle or ACV, is an amphibious craft capable of travelling over land, water, mud, ice, and other surfaces. In 2018, the market size of High Performance Hovercraft is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2018; while in China, the market size is valued at xx million US$ and will increase to
R&D Collaborative Projects by GD Rectifiers
GD Rectifiers have extensive experience in collaborative R&D projects and are proud to work with some of the UK’s pioneering power electronic companies to drive design and innovation forward. This R&D service helps drive GD Rectifiers forward as a cutting edge manufacturer embracing fundamental technologies that support product development that contribute to next generation products throughout: renewable energy, embedded systems, smart metrering and the rail industry. Power Assemblies, Controllers and
Transforming Pharmaceutical R&D with Data
ReportsWorldwide has announced the addition of a new report title Transforming Pharmaceutical R&D with Data to its growing collection of premium market research reports. Transforming Pharmaceutical R&D with Data In the current drug pricing environment, biopharmaceutical firms cannot afford to continue spending billions of dollars on development programs that are more than 90% likely to fail. Raising prices to compensate for expensive, risky research and development (R&D) is no longer an option
Noliac is expanding the R&D team
Noliac is looking for two new colleagues for the R&D team in Prague, Czech Republic: A Precision/Fine Mechanics and an Electroengineer. Precision/Fine Mechanics For the R&D team in Prague, Czech Republic, Noliac is looking for a Precision/Fine mechanics to work on modifying existing products and work with developing new. Noliac requires a colleague who: Is mechanically skilled with a focus on very small machinery. Holds a technical high school degree or an apprenticeship
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University
Rising R&D Funding for Nanotechnology
Global nanotechnology market has been registering marked increase in funds allocation by the countries across the world, especially with new product development that received huge momentum due to these funding. An increase in global public funding for R&D initiatives supports quick commercialization of nano-based products. Fundings from governments, corporations, and venture capital exhibited a CAGR growth of 1% during 2008-2012. In future, it is expected that nanotechnology funding will grow